Becton, Dickinson and Company (BD Biosciences) has recalled 464 vials of CD11b APC, an in vitro diagnostic product used for cell staining in medical testing. The affected products may cause low or dim fluorescence signals, which can lead to false negative results or the misdiagnosis of blood-related cancers (hematological malignancies). This defect could result in delayed medical treatment or the need to collect additional samples from patients. Consumers should identify if they have the affected vials marked with specific reference numbers and expiration dates for 2025.
The product's failure to properly stain cells causes a weak fluorescence signal that diagnostic equipment may fail to detect. This mechanism can hide the presence of malignant cells, potentially leading a healthcare provider to incorrectly conclude a patient is healthy or delaying critical treatment for cancer.
Manufacturer notification and guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.